COVID-19 Diagnosis and Management

Differential Diagnosis

• The International Journal of Surgery and Military Medical Research recommend ruling out other viral respiratory infections, including Influenza virus, Parainfluenza virus, Adenovirus, Respiratory syncytial virus, Metapneumovirus, and Mycoplasma pneumonia (with IgM testing helpful) 1, 2

Demographics and Diagnosis

• A higher percentage of COVID-19 diagnoses occur between ages 36-50 years, according to Nature Reviews Microbiology 3

Long COVID Management

• Long COVID management requires a symptom-based approach with multidisciplinary support, and recognition that symptoms can persist for years, particularly in cases of new-onset ME/CFS and dysautonomia, as recommended by Nature Reviews Microbiology 3
• Approximately 20% of people with COVID-19 experience symptoms lasting 5+ weeks, with common long COVID symptoms including fatigue (31-58% of patients), dyspnea (25-37% of patients), chest pain (6-17% of patients), cognitive dysfunction, sleep disorders, and anosmia/dysgeusia (13-21% of patients) 4, 5
• The initial approach to managing Long COVID symptoms should focus on a structured multidisciplinary assessment, symptom validation, and implementation of symptom-specific management strategies with energy conservation as a cornerstone of treatment, including blood tests (full blood count, kidney and liver function, C-reactive protein, ferritin, B-type natriuretic peptide, and thyroid function) 4
• A normal chest X-ray does not rule out lung disease, and a chest radiograph is recommended by 12 weeks for persistent respiratory symptoms 4
• Functional testing, including exercise capacity assessment and record of breathlessness, heart rate, and oxygen saturation during testing, is recommended to assess the patient's condition, along with a 3-minute active stand test (or 10 minutes if suspecting POTS) for patients with postural symptoms 4
• Patients with Long COVID should be referred to multidisciplinary rehabilitation services based on local resources, with a focus on management of fatigue as a key component, and implementing a structured daily routine with planned rest periods and careful grading of physical activity to avoid symptom exacerbation 4
• Providing information on setting realistic goals, symptom tracking, support groups, and online resources is essential for patient support, along with effective information sharing between services and continuity with the same healthcare team when possible 4
• Addressing psychological aspects alongside physical symptoms is essential, as overlooking mental health impacts can exacerbate the condition, and cognitive pacing strategies should be used to avoid cognitive overexertion 4, 3
• A carefully graded physical activity program tailored to avoid post-exertional malaise, starting with very gentle exercise and gradually increasing as tolerated, is recommended for patients with long COVID, as well as activity pacing to avoid post-exertional malaise 5, 3
• The evidence for specific pharmacological interventions for Long COVID remains limited, with current management focusing primarily on symptom-based supportive care, and medications with short half-life and low risk of drug-drug interactions should be used to manage severe anxiety in patients with COVID-19 5, 6
• Standard headache protocols with analgesics, trigger avoidance, and stress management techniques should be used to manage headaches in patients with COVID-19, and anti-inflammatory drugs and viral protease inhibitors may be considered in severe cases of neurological sequelae of COVID-19 7
• Vitamin B12 (methylcobalamin) supplementation at 1000-2000 mcg daily, folate at 1-5 mg daily, and vitamin B6 (pyridoxine) at 25-100 mg daily may help reduce thrombotic risk and improve clinical outcomes in long COVID patients with elevated homocysteine 8
• Encouraging a diet rich in B vitamins (leafy greens, legumes, eggs, meat) may help reduce homocysteine levels in long COVID patients, with consideration of methionine restriction (limiting animal proteins) to reduce homocysteine production potentially beneficial in some cases 5
• Vulnerable populations should receive additional support, and avoiding dismissing symptoms as psychological or exaggerated is crucial, as long COVID is a recognized medical condition, with multidisciplinary rehabilitation remaining the cornerstone of management 4, 5
• A symptom-based approach targeting fatigue, heat intolerance, and constipation, with particular attention to thyroid autoimmunity, is recommended for managing long COVID in perimenopausal women 5
• Venous thromboembolism prophylaxis should be considered for patients with hypercoagulability, and monitoring for signs of thrombotic events is critical in patients with elevated homocysteine and long COVID 7, 5
• A clinical assessment of symptoms over time, documenting the persistence, pattern, and progression of symptoms since acute COVID-19 infection, evaluating the impact on quality of life and daily functioning, and tracking symptom severity using validated tools is recommended by the ESCMID guidelines 5
• A basic laboratory assessment, including complete blood count, C-reactive protein, kidney function tests, liver function tests, and thyroid function tests, particularly for patients with fatigue and diarrhea, is recommended by the ESCMID guidelines 5
• Additional testing based on specific symptoms, such as orthostatic vital signs for dizziness and GI workup for gastrointestinal symptoms, should be considered as part of the clinical assessment, and assessing for improvement in long COVID symptoms is essential in monitoring the effectiveness of treatment 5

Special Considerations

• The following table summarizes the recommended laboratory tests for long COVID patients:

5